SM04755

DRUG3 trials

Sponsors

Biosplice Therapeutics, Inc.

Conditions

Colorectal CancerGastric CancerHepatic CancerPancreatic CancerTendinopathy

Phase 1

Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer

CompletedNCT02191761

Biosplice Therapeutics, Inc.Colorectal Cancer, Gastric Cancer, Hepatic Cancer +1

Start: 2014-06-19End: 2015-05-20Updated: 2018-09-07

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SM04755 Following Topical Administration to Healthy Subjects

CompletedNCT03229291

Biosplice Therapeutics, Inc.Tendinopathy

Start: 2016-11-03End: 2017-06-11Updated: 2017-07-25

A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers

CompletedNCT03502434

Biosplice Therapeutics, Inc.Tendinopathy

Start: 2017-09-11End: 2017-11-17Updated: 2018-04-18